Assessment of spinal arthrodesis in dorsolumbar spine trauma using hydroxyapatite, tricalcium phosphate, and 60% hydroxyapatite + 40% tricalcium phosphate: A comparative study

by Sumanta Pal, Kiran Kumar Mukhopadhyay, Anant Kumar Garg, Sanjay Kumar, Pradip Mukherjee
Published 2019-01-01

Tuberculosis of Distal Radius Presenting as Cystic Lesion in a Nine-Month-Old Infant: A Rare Case Report

by ANIRUDDHA SINHA SARKAR, ANANT KUMAR GARG, ABHISHEK BANDYOPADHYAY, SANJAY KUMAR, SUMANTA PAL
Published 2016-09-01

541 Investigating myeloid derived suppressor cells (MDSCs) and oligonucleotide based targeting of STAT3 in renal cell carcinoma

by Dayson Moreira, Sumanta Pal, JoAnn Hsu, Marice Alcantara, Chia-Yang Hung, Dongfang Wang
Published 2020-11-01

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database

by Sumanta Pal, Jun Gong, Shivani K. Mhatre, Shih-Wen Lin, Andy Surinach, Sarika Ogale, Rini Vohra, Herschel Wallen, Daniel George
Published 2019-06-01

B cells promote tumor progression via STAT3 regulated-angiogenesis.

by Chunmei Yang, Heehyoung Lee, Sumanta Pal, Veronica Jove, Jiehui Deng, Wang Zhang, Dave S B Hoon, Mark Wakabayashi, Stephen Forman, Hua Yu
Published 2013-01-01

Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer.

by Chunmei Yang, Heehyoung Lee, Veronica Jove, Jiehui Deng, Wang Zhang, Xueli Liu, Stephen Forman, Thanh H Dellinger, Mark Wakabayashi, Hua Yu, Sumanta Pal
Published 2013-01-01

645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis

by Sumanta Pal, Nazli Dizman, JoAnn Hsu, Nicholas Salgia, Milton L Greenberg, Andrew C Newman, Jonathan Skupsky, Zeynep Zengin, Luis Meza, Neal Chawla, Sabrina Salgia, Jasnoor Malhotra
Published 2020-11-01

Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma

by Thomas Powles, Toni K. Choueiri, Robert J. Motzer, Eric Jonasch, Sumanta Pal, Nizar M. Tannir, Sabina Signoretti, Rajesh Kaldate, Christian Scheffold, Evelyn Wang, Dana T. Aftab, Bernard Escudier, Daniel J. George
Published 2021-08-01

Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma

by Thomas Powles, Toni K. Choueiri, Robert J. Motzer, Eric Jonasch, Sumanta Pal, Nizar M. Tannir, Sabina Signoretti, Rajesh Kaldate, Christian Scheffold, Evelyn Wang, Dana T. Aftab, Bernard Escudier, Daniel J. George
Published 2021-09-01

Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T

by Jeffrey Huang, Sumanta Pal, Tanya Dorff, Owen T M Chan, Hideki Furuya, Ian Pagano, Yosuke Hirasawa, Jared Acoba, David Tamura, Minlu Zhang, Rebecca Waitz, Abhilash Dhal, Winston Haynes, John Shon, Mark Scholz, Charles Rosser
Published 2021-08-01

Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer

by Saul J. Priceman, Ethan A. Gerdts, Dileshni Tilakawardane, Kelly T. Kennewick, John P. Murad, Anthony K. Park, Brook Jeang, Yukiko Yamaguchi, Xin Yang, Ryan Urak, Lihong Weng, Wen-Chung Chang, Sarah Wright, Sumanta Pal, Robert E. Reiter, Anna M. Wu, Christine E. Brown, Stephen J. Forman
Published 2018-02-01

Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients

by Moom R. Roosan, Isa Mambetsariev, Rebecca Pharaon, Jeremy Fricke, Angel R. Baroz, Joseph Chao, Chen Chen, Mohd W. Nasser, Ramakanth Chirravuri-Venkata, Maneesh Jain, Lynette Smith, Susan E. Yost, Karen L. Reckamp, Raju Pillai, Leonidas Arvanitis, Michelle Afkhami, Edward W. Wang, Vincent Chung, Mihaela Cristea, Marwan Fakih, Marianna Koczywas, Erminia Massarelli, Joanne Mortimer, Yuan Yuan, Surinder K. Batra, Sumanta Pal, Ravi Salgia
Published 2021-06-01